on OXURION (EBR:OXUR)
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
On August 6, 2025, Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, announced the reception of transparency notifications from Atlas Special Opportunities II, LLC. This aligns with the Belgian Transparency legislation requirements. The notifications indicated changes in shareholdings regarding Oxurion's outstanding shares.
Atlas Special Opportunities II, LLC reported on July 24, 2025, that it held 2,353,539 of the 25,821,963 outstanding shares, thus falling below the 10% threshold. However, by July 25, 2025, a subsequent notification revealed an increase to 4,422,057 shares out of 36,983,581 outstanding, crossing above the 10% threshold due to recent share transactions.
This move showcases active shareholding adjustments within Oxurion. No further detailed outcomes have been shared.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news